Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'signaling pathways microbiology virology beta lactamase'

Search results for: 'signaling pathways microbiology virology beta lactamase'

Items 171-180 of 465

Page
per page
  1. JW 55
    A4529 JW 55
    Summary: PARP domain inhibitor
      insoluble in H2O; ≥19.25 mg/mL
  2. Wnt-C59
    A8685 Wnt-C59
     2 Citation
    Target: PORCN
    Summary: PORCN inhibitor,highly potent and selective
      .95 mg/mL
      insoluble in H2O; ≥18
  3. IWP-2
    A3512 IWP-2
     2 Citation
    Summary: Wnt production inhibitor,PORCN inhibitor
      ≥23.35 mg/mL
  4. Salinomycin
    A3785 Salinomycin
    Target: Antibiotic
    Summary: Polyether ionophore antibiotic;anti-cancer
  5. Anti-IL-2Rb/CD122 Antibody (Singapore ASTR patent anti-IL-2R beta / IL-2R gamma )
    F2013 Anti-IL-2Rb/CD122 Antibody (Singapore ASTR patent anti-IL-2R beta / IL-2R gamma )
    Summary: Anti-IL-2Rb/CD122 Antibody (Singapore ASTR patent anti-IL-2R beta / IL-2R gamma )
  6. SB202190 (FHPI)
    A1632 SB202190 (FHPI)
     5 Citation
    Target: p38
    Summary: P38 MAPK inhibitor
  7. CHIR-99021 (CT99021) HCl
    A8396 CHIR-99021 (CT99021) HCl
    Target: GSK-3
    Summary: GSK-3α/β inhibitor
      ≥25.1 mg/mL
  8. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     2 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive
      ≥23.27 mg/mL
  9. XAV-939
    A1877 XAV-939
     1 Citation
    Target: TNKS
    Summary: Tankyrase 1/2 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
  10. Vemurafenib (PLX4032, RG7204)
    A3004 Vemurafenib (PLX4032, RG7204)
     9 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥24.5 mg/mL

Items 171-180 of 465

Page
per page